ENTITY

Juno Therapeutics (JUNO US)

Analysis

Health Care • United States

Juno Therapeutics Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing immunotherapies for cancer and other research services.

Refresh

Focused

No publications yet

There aren’t any broker reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00